SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5ng6'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FM4_A_DXCA1002_0
(MAJOR POLLEN
ALLERGEN BET V 1-L)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 PHE A1005
VAL A1003
ILE A 944
SER A 986
LEU A1031
None
None
None
G  B  -2 ( 3.2A)
None
1.27A 1fm4A-5ng6A:
undetectable
1fm4A-5ng6A:
7.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OIP_A_VIVA1278_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 ILE A 195
LEU A 208
ILE A 278
LEU A  66
ILE A 113
None
0.88A 1oipA-5ng6A:
undetectable
1oipA-5ng6A:
11.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QZF_A_FOLA605_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 VAL A1004
LEU A1035
ILE A 900
LEU A 904
TYR A1076
None
1.09A 1qzfA-5ng6A:
undetectable
1qzfA-5ng6A:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QZF_B_FOLB609_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 VAL A1004
LEU A1035
ILE A 900
LEU A 904
TYR A1076
None
1.09A 1qzfB-5ng6A:
undetectable
1qzfB-5ng6A:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QZF_C_FOLC613_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 VAL A1004
LEU A1035
ILE A 900
LEU A 904
TYR A1076
None
1.09A 1qzfC-5ng6A:
undetectable
1qzfC-5ng6A:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QZF_D_FOLD617_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 VAL A1004
LEU A1035
ILE A 900
LEU A 904
TYR A1076
None
1.09A 1qzfD-5ng6A:
undetectable
1qzfD-5ng6A:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QZF_E_FOLE621_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 VAL A1004
LEU A1035
ILE A 900
LEU A 904
TYR A1076
None
1.09A 1qzfE-5ng6A:
undetectable
1qzfE-5ng6A:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_B_SAMB802_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 ARG A1016
ASP A1253
ASP A 939
GLU A 920
None
1.27A 1rjdB-5ng6A:
undetectable
1rjdB-5ng6A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_C_SAMC803_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 ARG A1016
ASP A1253
ASP A 939
GLU A 920
None
1.24A 1rjdC-5ng6A:
undetectable
1rjdC-5ng6A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YAJ_J_BEZJ5041_0
(CES1 PROTEIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 4 GLY A 701
SER A 695
ILE A 750
HIS A 697
None
1.24A 1yajJ-5ng6A:
undetectable
1yajJ-5ng6A:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CL5_B_SAMB1217_1
(CATECHOL
O-METHYLTRANSFERASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 SER A 322
TYR A 272
SER A  80
GLN A  77
None
0.87A 2cl5B-5ng6A:
undetectable
2cl5B-5ng6A:
10.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OIP_A_MTXA605_1
(CHAIN A, CRYSTAL
STRUCTURE OF DHFR)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 VAL A1004
LEU A1035
ILE A 900
LEU A 904
TYR A1076
None
1.15A 2oipA-5ng6A:
undetectable
2oipA-5ng6A:
17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QE6_A_SAMA400_1
(UNCHARACTERIZED
PROTEIN TFU_2867)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
3 / 3 ASN A 464
ARG A 467
ASP A 408
None
0.98A 2qe6A-5ng6A:
undetectable
2qe6A-5ng6A:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QE6_B_SAMB400_1
(UNCHARACTERIZED
PROTEIN TFU_2867)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
3 / 3 ASN A 464
ARG A 467
ASP A 408
None
0.99A 2qe6B-5ng6A:
undetectable
2qe6B-5ng6A:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QMZ_A_LDPA501_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 7 GLY A 761
PHE A 741
ILE A 728
PHE A 753
None
1.03A 2qmzA-5ng6A:
undetectable
2qmzB-5ng6A:
undetectable
2qmzA-5ng6A:
10.54
2qmzB-5ng6A:
10.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V7B_B_BEZB1529_0
(BENZOATE-COENZYME A
LIGASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 9 ALA A 924
TYR A 925
ALA A1256
GLY A1258
HIS A 922
None
1.35A 2v7bB-5ng6A:
undetectable
2v7bB-5ng6A:
17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VDB_A_NPSA1591_1
(SERUM ALBUMIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 8 PHE A 378
LEU A 377
PHE A 565
TYR A 562
None
0.85A 2vdbA-5ng6A:
undetectable
2vdbA-5ng6A:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3M_B_FOLB1188_0
(DIHYDROFOLATE
REDUCTASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 ALA A 416
LEU A 460
PHE A 407
ASN A 481
THR A 415
None
1.22A 2w3mB-5ng6A:
undetectable
2w3mB-5ng6A:
8.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEK_A_DIFA1375_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
3 / 3 LEU A 985
TYR A 984
GLN A 987
None
None
A  B  -3 ( 3.6A)
0.65A 2wekA-5ng6A:
undetectable
2wekA-5ng6A:
13.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YVL_B_SAMB602_1
(HYPOTHETICAL PROTEIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
3 / 3 GLU A1225
ASP A1253
TYR A 925
None
0.81A 2yvlB-5ng6A:
undetectable
2yvlB-5ng6A:
11.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZVJ_A_SAMA301_1
(CATECHOL
O-METHYLTRANSFERASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 SER A 322
TYR A 272
SER A  80
GLN A  77
None
0.91A 2zvjA-5ng6A:
undetectable
2zvjA-5ng6A:
10.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A9E_B_REAB1_1
(RETINOIC ACID
RECEPTOR ALPHA)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 11 PHE A 543
ILE A 478
PHE A 393
PHE A 482
LEU A 374
None
1.36A 3a9eB-5ng6A:
undetectable
3a9eB-5ng6A:
11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI9_X_SAMX501_0
(UPF0217 PROTEIN
MJ1640)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 9 ILE A 159
LEU A 142
SER A 145
GLU A 151
LEU A 152
None
1.06A 3ai9X-5ng6A:
undetectable
3ai9X-5ng6A:
9.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IA4_B_MTXB164_1
(DIHYDROFOLATE
REDUCTASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 MET A 352
LEU A 529
GLN A 532
SER A 503
ILE A 502
None
1.16A 3ia4B-5ng6A:
undetectable
3ia4B-5ng6A:
7.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 PHE A 786
TYR A 784
THR A 618
PHE A 600
None
1.31A 3ltwA-5ng6A:
undetectable
3ltwA-5ng6A:
11.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OWX_A_XRAA233_2
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 5 PHE A1126
ILE A1144
PHE A1128
PHE A1112
None
0.96A 3owxB-5ng6A:
undetectable
3owxB-5ng6A:
10.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R9C_A_ECLA452_1
(CYTOCHROME P450
164A2)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 LEU A 830
LEU A 630
ALA A 606
ASN A 617
LEU A 783
None
1.20A 3r9cA-5ng6A:
undetectable
3r9cA-5ng6A:
14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_B_T1CB405_1
(TETX2 PROTEIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 ASN A1093
GLY A1090
ALA A1079
GLY A1080
GLU A1006
None
1.22A 3v3oB-5ng6A:
undetectable
3v3oB-5ng6A:
14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_B_T1CB405_1
(TETX2 PROTEIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 GLN A1296
ASN A1093
GLY A1090
GLY A1080
GLU A1006
None
1.25A 3v3oB-5ng6A:
undetectable
3v3oB-5ng6A:
14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W68_D_VIVD301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
6 / 12 LEU A 830
ILE A 657
ILE A 620
VAL A 632
LEU A 783
PHE A 600
None
1.42A 3w68D-5ng6A:
undetectable
3w68D-5ng6A:
10.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_A_T1CA392_1
(TETX2 PROTEIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 11 ASN A1093
GLY A1090
ALA A1079
GLY A1080
GLU A1006
None
1.03A 4a6nA-5ng6A:
undetectable
4a6nA-5ng6A:
14.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AZT_A_SAMA1472_0
(METHYLTRANSFERASE
WBDD)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 GLY A1263
ALA A1259
ILE A 913
VAL A1004
ILE A1002
None
1.08A 4aztA-5ng6A:
undetectable
4aztA-5ng6A:
17.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DM8_A_REAA501_1
(RETINOIC ACID
RECEPTOR BETA)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 11 PHE A 123
LEU A 329
PHE A 119
SER A 116
ILE A  54
None
0.89A 4dm8A-5ng6A:
undetectable
4dm8A-5ng6A:
11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F93_B_SANB3004_1
(U5 SMALL NUCLEAR
RIBONUCLEOPROTEIN
200 KDA HELICASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 8 GLU A1175
GLU A1167
GLY A1148
SER A1149
None
1.01A 4f93B-5ng6A:
undetectable
4f93B-5ng6A:
21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FJP_A_NPSA711_1
(LACTOTRANSFERRIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 GLY A1090
PRO A1087
TYR A1260
GLY A1258
None
0.89A 4fjpA-5ng6A:
undetectable
4fjpA-5ng6A:
14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J7X_F_SASF805_1
(SEPIAPTERIN
REDUCTASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 LEU A1211
PHE A1112
PRO A1232
ASP A1113
ASP A1129
None
1.30A 4j7xF-5ng6A:
undetectable
4j7xF-5ng6A:
13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J7X_J_SASJ804_1
(SEPIAPTERIN
REDUCTASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 LEU A1211
PHE A1112
PRO A1232
ASP A1113
ASP A1129
None
1.37A 4j7xJ-5ng6A:
undetectable
4j7xJ-5ng6A:
13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JTP_A_ASCA802_0
(RRNA N-GLYCOSIDASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 5 TYR A 307
ILE A 304
ASN A 230
TYR A 231
None
1.01A 4jtpA-5ng6A:
undetectable
4jtpA-5ng6A:
11.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O1E_B_C2FB4000_1
(DIHYDROPTEROATE
SYNTHASE DHPS)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 4 LYS A 173
ASN A 602
ASP A 616
ASP A 129
None
1.49A 4o1eB-5ng6A:
undetectable
4o1eB-5ng6A:
12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q15_A_HFGA803_1
(PROLINE--TRNA LIGASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
3 / 3 GLU A1225
THR A 940
HIS A 922
None
0.75A 4q15A-5ng6A:
undetectable
4q15A-5ng6A:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q15_B_HFGB803_1
(PROLINE--TRNA LIGASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
3 / 3 GLU A1225
THR A 940
HIS A 922
None
0.79A 4q15B-5ng6A:
undetectable
4q15B-5ng6A:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 8 PHE A 489
LEU A 536
LEU A 374
PHE A 378
None
0.87A 4qopC-5ng6A:
undetectable
4qopC-5ng6A:
16.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R3A_B_RBFB402_2
(BLUE-LIGHT-ACTIVATED
HISTIDINE KINASE 2)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 ALA A 459
LEU A 460
ILE A 542
LEU A 399
GLY A 414
None
0.81A 4r3aB-5ng6A:
undetectable
4r3aB-5ng6A:
13.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RET_A_DGXA1107_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 LEU A 399
PHE A 543
GLU A 213
PHE A 561
LEU A 386
None
1.27A 4retA-5ng6A:
undetectable
4retA-5ng6A:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWD_F_377F401_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 7 GLU A 213
LEU A  76
PHE A 211
TYR A  83
None
1.04A 4twdF-5ng6A:
undetectable
4twdJ-5ng6A:
undetectable
4twdF-5ng6A:
12.66
4twdJ-5ng6A:
12.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWD_H_377H401_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 TYR A1076
ASN A1009
GLU A1028
PHE A1061
None
1.24A 4twdG-5ng6A:
undetectable
4twdH-5ng6A:
undetectable
4twdG-5ng6A:
12.66
4twdH-5ng6A:
12.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UW0_A_SAMA1506_0
(WBDD)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 GLY A1263
ALA A1259
ILE A 913
VAL A1004
ILE A1002
None
0.99A 4uw0A-5ng6A:
undetectable
4uw0A-5ng6A:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WG0_C_CHDC102_0
(NUCLEAR RECEPTOR
COACTIVATOR 2)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 7 LYS A1206
LEU A1207
LEU A1177
LEU A1178
None
0.80A 4wg0B-5ng6A:
undetectable
4wg0C-5ng6A:
undetectable
4wg0B-5ng6A:
2.14
4wg0C-5ng6A:
2.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WG0_L_CHDL103_0
(NUCLEAR RECEPTOR
COACTIVATOR 2)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 7 LEU A1177
LEU A1178
LYS A1206
LEU A1207
None
0.81A 4wg0L-5ng6A:
undetectable
4wg0M-5ng6A:
undetectable
4wg0L-5ng6A:
2.14
4wg0M-5ng6A:
2.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XDR_A_ADNA402_1
(FAD:PROTEIN FMN
TRANSFERASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 LEU A1264
GLY A1258
ALA A1259
ILE A 935
THR A 927
None
0.99A 4xdrA-5ng6A:
undetectable
4xdrA-5ng6A:
13.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YDQ_B_HFGB802_1
(PROLINE--TRNA LIGASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
3 / 3 GLU A1225
THR A 940
HIS A 922
None
0.73A 4ydqB-5ng6A:
undetectable
4ydqB-5ng6A:
17.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YJI_A_TYLA502_1
(ARYL ACYLAMIDASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 7 LEU A 803
GLY A1050
GLY A1049
ALA A1054
A  B  -1 ( 4.2A)
None
None
None
0.73A 4yjiA-5ng6A:
undetectable
4yjiA-5ng6A:
15.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YSH_B_GLYB401_0
(GLYCINE OXIDASE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 PHE A1128
GLY A1140
TYR A1130
ALA A1138
None
1.17A 4yshB-5ng6A:
undetectable
4yshB-5ng6A:
13.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZZB_C_ACTC401_0
(PROTON-GATED ION
CHANNEL)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 7 ILE A 774
PHE A 622
VAL A 777
ILE A 640
None
0.90A 4zzbC-5ng6A:
undetectable
4zzbD-5ng6A:
undetectable
4zzbC-5ng6A:
14.06
4zzbD-5ng6A:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G08_A_Z80A1187_1
(FREQUENIN 2)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 ILE A1286
TYR A1291
PHE A1294
THR A 927
None
1.01A 5g08A-5ng6A:
undetectable
5g08A-5ng6A:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HUA_A_FK5A201_1
(FK506-BINDING
PROTEIN 1)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 11 ARG A1150
PHE A1240
PHE A1126
LEU A1211
PHE A1091
None
1.47A 5huaA-5ng6A:
undetectable
5huaA-5ng6A:
5.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IH0_A_ERYA404_0
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E II)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 ILE A1085
HIS A1261
ALA A1138
ILE A1286
MET A1268
None
1.19A 5ih0A-5ng6A:
undetectable
5ih0A-5ng6A:
13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5INZ_D_DVAD15_0
(THETA DEFENSIN-2,
D-PEPTIDE
THETA DEFENSIN-2,
L-PEPTIDE)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
3 / 3 GLY A1188
CYH A1190
CYH A1116
None
0.92A 5inzB-5ng6A:
undetectable
5inzB-5ng6A:
1.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IWU_A_ERYA404_0
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E II)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 ILE A1085
HIS A1261
ALA A1138
ILE A1286
MET A1268
None
1.13A 5iwuA-5ng6A:
undetectable
5iwuA-5ng6A:
13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LJE_A_RTLA201_0
(RETINOL-BINDING
PROTEIN 1)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 12 LEU A1207
LEU A1178
SER A1146
ILE A1115
LEU A1095
None
1.12A 5ljeA-5ng6A:
undetectable
5ljeA-5ng6A:
7.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OM3_B_DXTB501_1
(ALPHA-1-ANTICHYMOTRY
PSIN)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 LEU A 374
SER A 375
PHE A 378
ASP A 379
None
0.67A 5om3A-5ng6A:
undetectable
5om3B-5ng6A:
undetectable
5om3A-5ng6A:
4.44
5om3B-5ng6A:
2.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5PHH_A_LDPA414_1
(LYSINE-SPECIFIC
DEMETHYLASE 4D)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 6 GLU A 213
ALA A 216
LEU A 212
TYR A  83
None
1.14A 5phhA-5ng6A:
undetectable
5phhA-5ng6A:
13.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_C_PCFC1801_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 9 ILE A  65
TYR A 190
ILE A 200
LEU A 208
None
0.69A 5vkqB-5ng6A:
undetectable
5vkqC-5ng6A:
undetectable
5vkqB-5ng6A:
21.99
5vkqC-5ng6A:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VLM_H_CVIH301_1
(REGULATORY PROTEIN
TETR)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
4 / 8 GLN A1056
GLY A1049
ILE A 997
ASP A1042
None
1.01A 5vlmH-5ng6A:
undetectable
5vlmH-5ng6A:
8.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HCO_A_FY5A1003_0
(ATP-BINDING CASSETTE
SUB-FAMILY G MEMBER
2)
5ng6 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1

(Francisella
tularensis)
5 / 11 ASN A 395
THR A 422
THR A 455
ILE A 456
VAL A 417
None
1.23A 6hcoA-5ng6A:
undetectable
6hcoB-5ng6A:
undetectable
6hcoA-5ng6A:
19.66
6hcoB-5ng6A:
19.66